Come up with a name for your new list and we'll add to it:
VIA Pharmaceuticals raised a round of funding on March 09, 2009. Investors include
Bay City Capital.
Drug development company targeting vascular inflammation. Using proprietary drug assessment tools, the company has established a screening system to identify drug candidates. VIA acquires anti-inflam…